-
Artificial intelligence based discovery of estrogen receptor activation function 2 (AF2) inhibitors as the first-in-class therapies for drug resistant breast cancers
Read MoreBreast cancer (BCa) is the most common cancer and the second cause of death from cancer among Canadian women. While antiestrogens are…